Cardiology
Major risks of dual and triple antithrombotic therapy in patients with newly diagnosed atrial fibrillation
According to Dr. Samy Suissa, Director of Clinical Epidemiology, Jewish General Hospital, and Professor of Epidemiology, McGill University in Montreal, Canada, "treating physicians need to consider the clinical effectiveness ...
Mar 5, 2013
0
0